| scholarly article | Q13442814 |
| P2093 | author name string | Mertz JA | |
| Picking WD | |||
| Picking WL | |||
| Marquart ME | |||
| P433 | issue | 4 | |
| P921 | main subject | Shigella flexneri | Q1644417 |
| P304 | page(s) | 401-408 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | Protein Expression and Purification | Q7251430 |
| P1476 | title | Cloning, expression, and affinity purification of recombinant Shigella flexneri invasion plasmid antigens IpaB and IpaC. | |
| P478 | volume | 8 |
| Q57170680 | A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei |
| Q39962325 | Abl tyrosine kinases are required for infection by Shigella flexneri |
| Q37120727 | Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q37335984 | Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine. |
| Q27664968 | Combination of Two Separate Binding Domains Defines Stoichiometry between Type III Secretion System Chaperone IpgC and Translocator Protein IpaB |
| Q37643320 | Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. |
| Q36946812 | Expression of Shigella flexneri ipaB Gene in Tobacco |
| Q41421816 | Expression, purification, structural and functional analysis of SycB: a type three secretion chaperone from Yersinia enterocolitica |
| Q42736388 | Genetic Dissection of the Signaling Cascade that Controls Activation of the Shigella Type III Secretion System from the Needle Tip. |
| Q34068059 | Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans |
| Q40123700 | Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. |
| Q39516559 | Interaction of Shigella flexneri IpaC with model membranes correlates with effects on cultured cells |
| Q41474021 | IpaC from Shigella and SipC from Salmonella possess similar biochemical properties but are functionally distinct |
| Q34120926 | Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults |
| Q43054516 | Physical characterization of MxiH and PrgI, the needle component of the type III secretion apparatus from Shigella and Salmonella |
| Q40977835 | Protein-protein interactions in the assembly of Shigella flexneri invasion plasmid antigens IpaB and IpaC into protein complexes |
| Q34003433 | Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans |
| Q39730227 | Structural characterization of the N terminus of IpaC from Shigella flexneri |
| Q44213448 | Structure-function analysis of invasion plasmid antigen C (IpaC) from Shigella flexneri. |
| Q52657631 | T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. |
| Q30438369 | The C-terminus of IpaC is required for effector activities related to Shigella invasion of host cells |
| Q33385013 | The C. elegans EMAP-like protein, ELP-1 is required for touch sensation and associates with microtubules and adhesion complexes |
| Q41414119 | YspC: a unique translocator exhibits structural alteration in the complex form with chaperone SycB. |
Search more.